New drug QRX-3 shows promise in slowing kidney disease
NCT ID NCT06948292
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This study tested a new drug, QRX-3, in 127 people with chronic kidney disease stages 3 to 5. The drug aims to protect kidney cells and improve kidney function by boosting a natural substance called NAD. Over 12 months, researchers measured how fast kidney function declined in those taking QRX-3 compared to those not taking it. The goal was to see if QRX-3 can slow down kidney disease progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC KIDNEY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Neukidney Inc
Pasedena, Texas, 77504, United States
Conditions
Explore the condition pages connected to this study.